ARALEZ PHARMACEUTICALS INC. Finite-Lived Intangible Asset, Expected Amortization, after Year Five
ARALEZ PHARMACEUTICALS INC. had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $136.69 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2018-05-08
- 2018-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $136.69M.
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $137.66M.
- 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $172.39M.
- 2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $170.98M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2018-03-31 | $136.69M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $137.66M 10-K · filed 2018-03-14 |
| 2017-09-30 | $172.39M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $170.98M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $170.12M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $169.78M 10-K · filed 2017-03-13 |
| 2016-09-30 | $75.92M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $52.26M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $49.60M 10-Q · filed 2016-05-10 |